Confluence Discovery Technologies Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 34

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $24.3M

Confluence Discovery Technologies General Information

Description

Developer of kinase inhibitors intended to treat cancer and inflammatory disease. The company's inhibitors target key enzymes involved in the regulation of cancer growth, survival, and metastasis or in the reduction of chronic inflammation, enabling healthcare providers to treat cancer and autoimmune or inflammatory diseases.

Contact Information

Formerly Known As
Confluence Life Sciences Inc.
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 4340 Duncan Avenue
  • Suite 400
  • Saint Louis, MO 63110
  • United States
+1 (314)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 4340 Duncan Avenue
  • Suite 400
  • Saint Louis, MO 63110
  • United States
+1 (314)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Confluence Discovery Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 03-Aug-2017 $24.3M Completed Generating Revenue
10. Grant 01-Jan-2017 Completed Generating Revenue
9. Later Stage VC (Series A1) 06-Apr-2016 Completed Product Development
8. Grant 01-Jan-2016 Completed Product Development
7. Early Stage VC 23-Jul-2015 Completed Product Development
6. Early Stage VC (Series A) 04-Feb-2014 Completed Product Development
5. Grant 01-Jan-2014 Completed Product Development
4. Early Stage VC 24-Oct-2013 Completed Startup
3. Grant 02-May-2013 $289K $4.2M Completed Startup
2. Early Stage VC (Series A) 17-Sep-2012 $4.2M $4.2M Completed Startup
To view Confluence Discovery Technologies’s complete valuation and funding history, request access »

Confluence Discovery Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A Prime
Series A
To view Confluence Discovery Technologies’s complete cap table history, request access »

Confluence Discovery Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of kinase inhibitors intended to treat cancer and inflammatory disease. The company's inhibitors target key en
Drug Discovery
Saint Louis, MO
34 As of 2026

Lyon, France
 

Santa Monica, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Confluence Discovery Technologies Competitors (12)

One of Confluence Discovery Technologies’s 12 competitors is Phaxiam, a Formerly VC-backed company based in Lyon, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Phaxiam Formerly VC-backed Lyon, France
Kite Pharma Formerly VC-backed Santa Monica, CA
CTI BioPharma Formerly VC-backed Seattle, WA
Aura Biosciences Formerly VC-backed Boston, MA
Amgen Formerly PE-Backed Thousand Oaks, CA
You’re viewing 5 of 12 competitors. Get the full list »

Confluence Discovery Technologies Patents

Confluence Discovery Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240002380-A1 Rev-erb agonists Inactive 16-Oct-2020
FR-3110963-A1 The industrial continuous food cooker Inactive 28-May-2020
FR-2475108-A1 Elastically mounted roller blind - has twisted elastic tie providing small and constant recall force for blind curtain Inactive 04-Feb-1980 E06B9/60

Confluence Discovery Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Confluence Discovery Technologies Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accelerate St. Louis Accelerator/Incubator Minority
BioGenerator Ventures Venture Capital Minority
DFJ Mercury Venture Capital Minority
Epidarex Capital Venture Capital Minority
Helix Funds Real Estate Minority
You’re viewing 5 of 10 investors. Get the full list »

Confluence Discovery Technologies FAQs

  • When was Confluence Discovery Technologies founded?

    Confluence Discovery Technologies was founded in 2010.

  • Where is Confluence Discovery Technologies headquartered?

    Confluence Discovery Technologies is headquartered in Saint Louis, MO.

  • What is the size of Confluence Discovery Technologies?

    Confluence Discovery Technologies has 34 total employees.

  • What industry is Confluence Discovery Technologies in?

    Confluence Discovery Technologies’s primary industry is Drug Discovery.

  • Is Confluence Discovery Technologies a private or public company?

    Confluence Discovery Technologies is a Private company.

  • What is the current valuation of Confluence Discovery Technologies?

    The current valuation of Confluence Discovery Technologies is .

  • What is Confluence Discovery Technologies’s current revenue?

    The current revenue for Confluence Discovery Technologies is .

  • How much funding has Confluence Discovery Technologies raised over time?

    Confluence Discovery Technologies has raised $10M.

  • Who are Confluence Discovery Technologies’s investors?

    Accelerate St. Louis, BioGenerator Ventures, DFJ Mercury, Epidarex Capital, and Helix Funds are 5 of 10 investors who have invested in Confluence Discovery Technologies.

  • Who are Confluence Discovery Technologies’s competitors?

    Phaxiam, Kite Pharma, CTI BioPharma, Aura Biosciences, and Amgen are some of the 12 competitors of Confluence Discovery Technologies.

  • When was Confluence Discovery Technologies acquired?

    Confluence Discovery Technologies was acquired on 03-Aug-2017.

  • Who acquired Confluence Discovery Technologies?

    Confluence Discovery Technologies was acquired by Aclaris Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process